Investments in Other Entities (Tables)

12 Months Ended

Dec. 31, 2020

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Equity Method Investments, Financial Statement Information

Investments in other entities – equity method consisted of the following (in thousands):

	December 31, 2019		Allocation of Net Income (Loss)		Additional/ Initial Investment		Contribution		Sale		December 31, 2020
LaSalle Medical Associates – IPA Line of Business	$	6,396	$	276	$	6,375	$	—	$	—	$	13,047
Pacific Medical Imaging & Oncology Center, Inc.	1,396		17		—		—		—		1,413
Universal Care, Inc.	1,438		3,560		—		—		(4,998)		—
Diagnostic Medical Group	2,334		279		—		—		—		2,613
531 W. College, LLC – related party	16,698		(448)		—		950		—		17,200
MWN, LLC – related party	165		10		—		—		(175)		—
One MSO, LLC - related party	—		—		2,395		—		—		2,395
Tag-6 Medical Investment Group, LLC - related party	—		—		4,516		—		—		4,516
Tag-8 Medical Investment Group, LLC - related party	—		—		2,108		—		—		2,108
	$	28,427	$	3,694	$	15,394	$	950	$	(5,173)	$	43,292

LMA’s unaudited summarized balance sheets at December 31, 2020 and 2019 and unaudited summarized statements of operations for the years ended December 31, 2020 and 2019 are as follows (in thousands):

Balance Sheets

	December 31, 2020 (unaudited)		December 31, 2019 (unaudited)
Assets
Cash and cash equivalents	$	9,350	$	6,345
Receivables, net	3,918		5,123
Other current assets	881		3,526
Loan receivable	2,250		2,250
Restricted cash	691		684
Total assets	$	17,090	$	17,928
Liabilities and Stockholders’ Deficit
Current liabilities	$	21,589	$	23,530
Stockholders’ deficit	(4,499)		(5,602)
Total liabilities and stockholders’ deficit	$	17,090	$	17,928

Statements of Operations

	Year Ended December 31, 2020 (unaudited)		Year Ended December 31, 2019 (unaudited)
Revenues	$	186,964	$	194,020
Expenses	185,724		205,153
Income (loss) from operations	1,240		(11,133)
Other income	8		—
Income (loss) before income tax benefit	1,248		(11,133)
Income tax benefit	—		—
Net income (loss)	$	1,248	$	(11,133)

UCI’s unaudited balance sheet at December 31, 2019 and unaudited statements of operations for the four months ended April 30, 2020 and twelve months ended December 31, 2019 are as follows (in thousands):

Balance Sheet

	December 31, 2019 (unaudited)
Assets
Cash	$	33,890
Receivables, net	63,843
Other current assets	38,280
Other assets	882
Property and equipment, net	4,021
Total assets	$	140,916
Liabilities and stockholders’ deficit
Current liabilities	$	128,330
Other liabilities	33,133
Stockholders’ deficit	(20,547)
Total liabilities and stockholders’ deficit	$	140,916

Statements of Operations

	Four Months Ended April 30, 2020 (unaudited)		Year Ended December 31, 2019 (unaudited)
Revenues	$	195,308	$	500,375
Expenses	189,028		502,567
Income (loss) before income tax provision	6,280		(2,192)
Income tax provision	—		258
Net income (loss)	$	6,280	$	(2,450)

531 W. College LLC’s unaudited balance sheets at December 31, 2020 and 2019 and unaudited statements of operations for the years ended December 31, 2020 and 2019 are as follows (in thousands):

Balance Sheets

	December 31, 2020 (unaudited)		December 31, 2019 (unaudited)
Assets
Cash	$	648	$	139
Other current assets	17		17
Other assets	70		70
Property and equipment, net	33,697		33,581
Total assets	$	34,432	$	33,807
Liabilities and Stockholders’ Equity
Current liabilities	$	32	$	1,061
Stockholders’ equity	34,400		32,746
Total liabilities and stockholders’ equity	$	34,432	$	33,807

Statements of Operations

	Year Ended December 31, 2020 (unaudited)		Year Ended December 31, 2019 (unaudited)
Revenues	$	—	$	—
Expenses	1,053		1,010
Loss from operations	(1,053)		(1,010)
Other income	64		475
Provision for Income Taxes	3		—
Net loss	$	(992)	$	(535)

Schedule of Equity Method Investment, Gain on Sale Information

The gain on sale of equity method investment recognized in connection with this transaction was determined as follows (in thousands):

	Amount
Cash proceeds (excludes proceeds to settle indebtedness owed to APC from UCI)	$	52,743
Preferred shares in Bright Health, Inc.	36,179
Beneficial interest in UCI	15,723
Less: Carrying value of equity method investment on date of sale	(4,998)
Gain on sale of equity method investment	$	99,647